Julian Baker’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-102,205
Closed -$2.86M 115
2019
Q3
$2.86M Buy
102,205
+2,800
+3% +$45.4K 0.02% 80
2019
Q2
$1.4M Buy
+99,405
New +$945K 0.01% 91

Julian Baker's DOVA Position: Q4 2019 in Review

Julian Baker sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 102,205 shares — an estimated $2.86M sold.

Julian Baker first reported a position in DOVA in Q2 2019 and held it in 2 quarters. The position peaked at $2.86M in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • Julian Baker reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Julian Baker sold 102,205 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $2.86M.
  • Julian Baker first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
  • Julian Baker's Dova Pharmaceuticals, Inc. Common Stock position peaked at $2.86M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Baker Bros. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.